Business Context and Reporting Period
This Form 6-K filing by Mainz Biomed N.V. (noted as Quantum Cyber N.V. in request metadata) covers the month of November 2023, specifically reporting on events occurring on November 13, 2023. The registrant is a foreign private issuer headquartered in Mainz, Germany.
Key Financial Metrics
The filing does not provide standard financial metrics such as revenue, profit, cash flow, margins, or existing debt levels. The primary financial data relates to a capital raise event:
- Capital Raised: Approximately $5.0 million.
- Instrument Type: Registered direct offering of ordinary shares (or pre-funded warrants) and warrants.
- Effective Purchase Price: $1.20 per ordinary share (or pre-funded warrant) plus associated warrant.
- Shares Issued: 4,166,667 ordinary shares (or pre-funded warrants).
- Warrants Issued: Warrants to purchase up to 4,166,667 shares.
- Warrant Exercise Price: $1.20 per share.
- Warrant Term: Immediately exercisable until the fifth anniversary of issuance.
Material Changes
The filing reports a material change in the company's capital structure through the execution of a securities purchase agreement with several institutional investors. This transaction increases the company's equity capital by approximately $5.0 million and introduces new warrant obligations.
Guidance, Outlook, and Risks
The filing text does not contain specific forward-looking guidance, management commentary on operational outlook, or a detailed discussion of risks and contingencies beyond the terms of the offering. The primary focus is the announcement of the pricing and terms of the registered direct offering.
Investor Verification Checklist
- Verify the final closing date and actual net proceeds received from the $5.0 million offering.
- Confirm the exact number of pre-funded warrants versus ordinary shares issued to investors.
- Review the updated capitalization table to assess dilution impact on existing shareholders.
- Check for any subsequent filings regarding the use of proceeds from this capital raise.